- Home
- MRSN vs EPM Comparison
MRSN vs EPM Comparison
Compare MRSN & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRSN | EPM |
|---|---|---|
| Founded | 2001 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.8M | 136.3M |
| IPO Year | 2017 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MRSN | EPM |
|---|---|---|
| Price | $27.78 | $4.21 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $30.38 | $4.75 |
| AVG Volume (30 Days) | 237.3K | ★ 406.8K |
| Earning Date | 11-14-2025 | 11-11-2025 |
| Dividend Yield | N/A | ★ 11.40% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $33,180,000.00 | ★ $85,232,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.21 | $3.71 |
| 52 Week High | $70.73 | $5.74 |
Technical Indicators
Market Signals| Indicator | MRSN | EPM |
|---|---|---|
| Relative Strength Index (RSI) | 83.68 | 51.70 |
| Support Level | $27.31 | $4.35 |
| Resistance Level | $28.36 | $3.86 |
| Average True Range (ATR) | 0.52 | 0.13 |
| MACD | -0.26 | 0.05 |
| Stochastic Oscillator | 51.65 | 84.75 |
Price Performance
Historical ComparisonAbout MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.